These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9464659)

  • 21. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.
    Bayer TA; Jäkälä P; Hartmann T; Havas L; McLean C; Culvenor JG; Li QX; Masters CL; Falkai P; Beyreuther K
    Neurosci Lett; 1999 May; 266(3):213-6. PubMed ID: 10465711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
    Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
    Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicatalytic proteinase is present in Lewy bodies and neurofibrillary tangles in diffuse Lewy body disease brains.
    Kwak S; Masaki T; Ishiura S; Sugita H
    Neurosci Lett; 1991 Jul; 128(1):21-4. PubMed ID: 1656333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell death mechanisms in Parkinson's disease.
    Jellinger KA
    J Neural Transm (Vienna); 2000; 107(1):1-29. PubMed ID: 10809400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease.
    Li JY; Englund E; Widner H; Rehncrona S; Björklund A; Lindvall O; Brundin P
    Mov Disord; 2010 Jun; 25(8):1091-6. PubMed ID: 20198645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies.
    Dzamko N; Gysbers AM; Bandopadhyay R; Bolliger MF; Uchino A; Zhao Y; Takao M; Wauters S; van de Berg WD; Takahashi-Fujigasaki J; Nichols RJ; Holton JL; Murayama S; Halliday GM
    Mov Disord; 2017 Mar; 32(3):423-432. PubMed ID: 27911006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lewy bodies in Parkinson's disease: histological, immunohistochemical, and interferometric examinations].
    Voronkov DN; Salkov VN; Anufriev PL; Khudoerkov RM
    Arkh Patol; 2018; 80(4):9-13. PubMed ID: 30059066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies.
    Trimmer PA; Borland MK; Keeney PM; Bennett JP; Parker WD
    J Neurochem; 2004 Feb; 88(4):800-12. PubMed ID: 14756800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical localization of apoptosome-related proteins in Lewy bodies in Parkinson's disease and dementia with Lewy bodies.
    Kawamoto Y; Ito H; Ayaki T; Takahashi R
    Brain Res; 2014 Jul; 1571():39-48. PubMed ID: 24835407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression and redistribution of the antiapoptotic molecule Bcl-xL in Parkinson's disease.
    Hartmann A; Mouatt-Prigent A; Vila M; Abbas N; Perier C; Faucheux BA; Vyas S; Hirsch EC
    Neurobiol Dis; 2002 Jun; 10(1):28-32. PubMed ID: 12079401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failure of the ubiquitin-proteasome system in Parkinson's disease.
    McNaught KS; Olanow CW; Halliwell B; Isacson O; Jenner P
    Nat Rev Neurosci; 2001 Aug; 2(8):589-94. PubMed ID: 11484002
    [No Abstract]   [Full Text] [Related]  

  • 33. Accumulation of HAX-1 and PARL in brainstem- and cortical-type Lewy bodies in Parkinson's disease and dementia with Lewy bodies.
    Kawamoto Y; Ayaki T; Urushitani M; Ito H; Takahashi R
    J Neurol Sci; 2020 Aug; 415():116928. PubMed ID: 32470650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease.
    Tatton NA
    Exp Neurol; 2000 Nov; 166(1):29-43. PubMed ID: 11031081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.
    Chung KK; Zhang Y; Lim KL; Tanaka Y; Huang H; Gao J; Ross CA; Dawson VL; Dawson TM
    Nat Med; 2001 Oct; 7(10):1144-50. PubMed ID: 11590439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease.
    Iannaccone S; Cerami C; Alessio M; Garibotto V; Panzacchi A; Olivieri S; Gelsomino G; Moresco RM; Perani D
    Parkinsonism Relat Disord; 2013 Jan; 19(1):47-52. PubMed ID: 22841687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pael-R is accumulated in Lewy bodies of Parkinson's disease.
    Murakami T; Shoji M; Imai Y; Inoue H; Kawarabayashi T; Matsubara E; Harigaya Y; Sasaki A; Takahashi R; Abe K
    Ann Neurol; 2004 Mar; 55(3):439-42. PubMed ID: 14991825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic approach to studying Parkinson's disease.
    Zhang J; Goodlett DR
    Mol Neurobiol; 2004 Jun; 29(3):271-88. PubMed ID: 15181239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levodopa-nonresponsive Lewy body parkinsonism: clinicopathologic study of two cases.
    Mark MH; Sage JI; Dickson DW; Schwarz KO; Duvoisin RC
    Neurology; 1992 Jul; 42(7):1323-7. PubMed ID: 1620341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bcl-2 and Bax protein expression in human myopathies.
    Olivé M; Ferrer I
    J Neurol Sci; 1999 Mar; 164(1):76-81. PubMed ID: 10385052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.